News
So far this year, just 16 funded U.S. startups in the biotech, drug discovery and medical device spaces have made their ...
Caris Life Sciences CEO and chairman David Dean Halbert, celebrates the company's initial public offering and listing on the Nasdaq exchange by ringing the opening bell on Wednesday, June 18, 2025.
21h
Investor's Business Daily on MSNCaris Life Sciences Earns Relative Strength Rating Upgrade
Caris Life Sciences is now considered extended and out of buy range after clearing a 30.70 buy point in a first-stage ipo base. See if the stock forms a new pattern or follow-on buying opportunity ...
Caris Life Sciences (CAI) stock is expected to make its trading debut on Wednesday after the company priced its IPO at $21/share. Read more here.
Caris Life Sciences, an AI-driven precision oncology company, is targeting a $5.35 billion valuation in its U.S. initial public offering, aiming to raise up to $423.5 million. The Irving, Texas ...
2d
Investor's Business Daily on MSNStocks To Watch: Caris Life Sciences Sees Relative Strength Rating Jump To 86
Caris Life Sciences shows improving price performance, earning an upgrade to its IBD Relative Strength Rating from 73 to 86.
IRVING, Texas, June 17, 2025 /PRNewswire/ -- Caris Life Sciences® (Caris), a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer, today announced the ...
IRVING, Texas, May 23, 2025 /PRNewswire/ -- Caris Life Sciences® ("Caris"), a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer, today announced that it ...
IRVING, Texas, June 9, 2025 /PRNewswire/ -- Caris Life Sciences® ("Caris"), a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer, today announced that it ...
Irving-based Caris Life Sciences filed to go public on the Nasdaq and revealed a significant revenue jump between 2023 and 2024. Still, the company remains unprofitable and is grappling with a ...
The initial public offering price is expected to be between $16.00 and $18.00 per share. Caris has applied to list its common stock on the Nasdaq Global Select Market under the ticker symbol "CAI." ...
Caris Life Sciences Files Registration Statement for Proposed Initial Public Offering Provided by PR Newswire May 23, 2025, 2:54:00 PM ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results